N04.22
Secondary membranous nephropathy with nephrotic syndrome
Clinical Classification Guidelines
Use Additional Code
- code, if applicable, for adverse effect of drug causing membranous nephropathy
Code First
- , if applicable, other disease or disorder or poisoning causing membranous nephropathy
Medical Intelligence & Overview
Secondary membranous nephropathy with nephrotic syndrome, classified under ICD-10 code N04.22, is a kidney disorder characterized by damage to the small blood vessels in the kidneys known as the glomeruli. This damage leads to significant protein loss in the urine, resulting in the clinical condition known as nephrotic syndrome. In contrast to primary membranous nephropathy, which has no identifiable cause, the secondary form is associated with other underlying health conditions or external factors. Understanding this diagnosis involves exploring what causes the condition, its signs and symptoms, methods of diagnosis, and possible approaches to management.
Causes & Symptoms
Clinical Causes: Autoimmune disorders, such as lupus erythematosus, which trigger immune system attacks on the kidney tissues. Certain infections including hepatitis B and C, syphilis, or malaria that can provoke kidney inflammation. Use or exposure to specific medications like nonsteroidal anti-inflammatory drugs (NSAIDs), penicillamine, or captopril. Underlying malignancies, including solid tumors or lymphomas, which may induce immune reactions affecting the kidneys. Other systemic diseases or conditions that lead to immune complexes depositing in the glomeruli.
Key Symptoms: Extensive swelling, especially around the eyes, ankles, and stomach due to fluid retention. Foamy or frothy urine resulting from high protein levels being excreted. Sudden weight gain linked to fluid buildup. High blood pressure, which may be present or develop over time. Fatigue and weakness stemming from anemia or overall health decline. Reduced urine output in some cases, although urine may appear normal at times.
Diagnostic & Treatment
Diagnosis Path: Urinalysis tests revealing high levels of protein and possibly blood in the urine. Blood tests measuring serum albumin, cholesterol, and kidney function markers like serum creatinine and blood urea nitrogen (BUN). Detection of immune complexes or underlying infections through specific blood tests. Imaging studies such as ultrasound to assess kidney size and structure. Kidney biopsy, viewed under a microscope, confirming the presence of membranous changes and identifying secondary causes.
Treatment Protocols: Managing the underlying condition that is causing the secondary membranous nephropathy. Use of medications like corticosteroids and immunosuppressants to dampen immune responses. Angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) to reduce proteinuria and control blood pressure. Dietary modifications, including reducing salt intake and maintaining a balanced diet to support kidney health. Monitoring and treating complications such as blood clots, which may be more likely due to loss of proteins that prevent clot formation. In some cases, plasmapheresis or other advanced therapies may be necessary to remove harmful immune complexes.
Clinical Advice & FAQs
Billing Guidance
Is N04.22 a billable ICD-10 code?
Yes, N04.22 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report N04.22?
Clinical documentation must specify the nature of Secondary membranous nephropathy with nephrotic syndrome and any associated comorbidities for accurate reporting.
Cite this Clinical Reference